Prophylactic Amiodarone for Shockable Cardiac Arrest

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 302 participants.

Also called NCT04845607

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 302 participants (planned count) (from the registry)
Sponsor
Won Young Kim (from the registry)
Registry
  • NCT NCT04845607
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04845607. Randomized; no masking; primary purpose prevention. Start 2021-04-01 (actual); primary completion 2023-02-28 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prophylactic Amiodarone for Shockable Cardiac Arrest
Condition
Ventricular Arrythmia
Intervention (Drug)
Amiodarone Injection
Lead sponsor
Won Young Kim (class: other)

Record details

Record id
cardio:ct-nct04845607
Content hash
c56ebbe99a1388a7fb8f2d2317fa957e3a689e4329c484ef4ab1595b6324050e